A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
A clinical trial to assess the effect of celecoxib 200 milligrams (mg) once daily and 400
milligrams (mg) once daily compared to diclofenac three times daily in the treatment of
Ankylosing Spondylitis (AS) for 12 weeks. This will be used to confirm the results of a prior
6 week trial.